Johnson & Johnson unveils plans to build a $1 billion cell therapy manufacturing facility in Lower Gwynedd Township, creating thousands of jobs and expanding next-generation cancer treatment production with state support.
The global health care company says the new site on Sumneytown Pike in the Spring House section will replace an existing building and focus on advanced cell therapy treatments targeting cancer and other diseases. Construction is set to begin later this year, with the facility expected to be fully operational by 2031.
Company Invests $1B In Next-Generation Cancer Treatments
Johnson & Johnson says the state-of-the-art facility will manufacture next-generation cell therapies designed to fight complex cancers. Company leaders describe the investment as both a medical and economic commitment to the region.
“For someone facing cancer, weeks can feel like years,” CEO Joaquin Duato says. “What we are building is manufacturing excellence and hope.”
Duato says Pennsylvania’s skilled workforce and research institutions played a central role in the company’s decision to expand in Montgomery County. “What draws us to Pennsylvania and keeps us here is its extraordinary workforce, the talent, leading universities and community colleges, and a business-friendly environment that lets us invest, innovate and grow,” he says.
The new plant will support production capacity for innovative treatments that rely on reengineering a patient’s own cells to target disease.
Project Promises Thousands Of Jobs Over Next Decade
State and local officials say the project will deliver significant economic benefits. During development, the construction phase is expected to create 4,000 jobs. Once complete, the facility is projected to generate 500 permanent biotechnology positions over the next 12 years.
Pennsylvania Gov. Josh Shapiro says the investment will strengthen both public health and the state’s economy. He says the project reflects Pennsylvania’s growing role in the life sciences industry.
Montgomery County Commissioner Jamila Winder says the county continues to attract major pharmaceutical and biotechnology companies because of its infrastructure and workforce.
“When a global innovator like Johnson & Johnson chooses to invest $1 billion in our community, the impact is profound,” Winder says. “It’s no wonder some of the most innovative pharmaceutical companies are here because in Montgomery County, they get access to our highly skilled workforce, our robust infrastructure, and our major institutions of medicine and education.”
State Provides $41M In Grants And Tax Credits
State officials say Pennsylvania is contributing more than $41 million in grants and tax credits to support the project. The incentives are designed to encourage business growth and long-term investment in the region’s life sciences sector.
Local leaders say the facility will reinforce Montgomery County’s reputation as a biotechnology hub and deepen its ties to academic and medical institutions across the state.
The company says it will release additional details about the construction timeline and hiring plans as the project advances.
